Facebook-f Twitter Linkedin-in
January 11, 2025
  1. Home
  2. Buyout News

Category: Pharma and Healthcare

Buyout News Renovo Solutions Receives Growth Investment from Water Street Healthcare Partners

Renovo Solutions Receives Growth Investment from Water Street Healthcare Partners

  • January 10, 2022

Angel / Venture Transcarent Raises $200 Million in Series C Funding Highlighting Growing Demand for a Different Health and Care Experience Aligned with the Needs of Self-Insured Employers

Transcarent Raises $200 Million in Series C Funding Highlighting Growing Demand for a Different Health and Care Experience Aligned with the Needs of Self-Insured Employers

  • January 10, 2022

Angel / Venture Diana Health Launches with $11M Series A Led by LRVHealth and .406 Ventures to Redesign Maternity and Women’s Health Programs at Leading Hospitals

Diana Health Launches with $11M Series A Led by LRVHealth and .406 Ventures to Redesign Maternity and Women’s Health Programs at Leading Hospitals

  • January 10, 2022

Angel / Venture eternalHealth Raises $10 Million Series A Funding After Initial $10 Million in Seed Financing in Summer

eternalHealth Raises $10 Million Series A Funding After Initial $10 Million in Seed Financing in Summer

  • January 10, 2022

Pharma and Healthcare KKR Closes $4.0 Billion Health Care Strategic Growth Fund II

KKR Closes $4.0 Billion Health Care Strategic Growth Fund II

  • January 10, 2022

Successor Fund Reaffirms Firm’s Commitment to Investing in Innovative Health Care Growth Companies MENLO PARK, Calif. & NEW YORK--(BUSINESS WIRE)-- KKR, a leading global investment firm, today announced the final closing of KKR Health Care

biopharmaceutical KKR closes Health Care Strategic Growth Fund II on $4bn, almost 3x fund I

KKR closes Health Care Strategic Growth Fund II on $4bn, almost 3x fund I

Global buyout giant KKR has closed KKR Health Care Strategic Growth Fund II on $4bn, just shy of tripling the size of its $1.45bn predecessor fund I which was closed in 2017. The post KKR

Europe KKR closes USD 4bn healthcare fund

KKR closes USD 4bn healthcare fund

Global private equity firm KKR has closed a USD 4bn fund for healthcare investments in Europe and North America.

Available to all R1 RCM to acquire New Mountain Capital-backed Cloudmed at $4.1bn enterprise value

R1 RCM to acquire New Mountain Capital-backed Cloudmed at $4.1bn enterprise value

New Mountain Capital has exited healthcare provider revenue management system Cloudmed to Nasdaq-listed RI RCM in an all stock transaction which valued the company at $4.1bn, including $857m of net debt. The post R1 RCM

Buyout News mPulse Mobile Acquires HealthCrowd and Receives Growth Investment from PSG

mPulse Mobile Acquires HealthCrowd and Receives Growth Investment from PSG

  • January 9, 2022

Buyout News Littlejohn Capital Announces Acquisition of Alto Healthcare Staffing Buoyed by Industry Tailwinds, Alto Poised for Geographic Expansion

Littlejohn Capital Announces Acquisition of Alto Healthcare Staffing Buoyed by Industry Tailwinds, Alto Poised for Geographic Expansion

  • January 9, 2022

Deal News Maze Therapeutics Announces $190 Million Financing to Support the Advancement of Nine Precision Medicine Programs and Compass Platform for Genetically Defined Diseases

Maze Therapeutics Announces $190 Million Financing to Support the Advancement of Nine Precision Medicine Programs and Compass Platform for Genetically Defined Diseases

  • January 9, 2022

Angel / Venture Little Otter Raises $22M Series A to Combat the Mental Health Crisis Plaguing Today’s Youth

Little Otter Raises $22M Series A to Combat the Mental Health Crisis Plaguing Today’s Youth

  • January 5, 2022

Pharma and Healthcare Jim Hinton, Former CEO of Baylor Scott & White Health, Joins Welsh, Carson, Anderson & Stowe as Healthcare Operating Partner

Jim Hinton, Former CEO of Baylor Scott & White Health, Joins Welsh, Carson, Anderson & Stowe as Healthcare Operating Partner

  • January 5, 2022

Angel / Venture Korro Bio Completes $116M Series B Financing to Expand the Frontier of Genetic Medicine Through Its Pipeline of RNA Editing Programs

Korro Bio Completes $116M Series B Financing to Expand the Frontier of Genetic Medicine Through Its Pipeline of RNA Editing Programs

  • January 4, 2022

Angel / Venture SalioGen Therapeutics Closes $115 Million Oversubscribed Series B Financing to Advance Gene Coding™ – A New Category of Genetic Medicine

SalioGen Therapeutics Closes $115 Million Oversubscribed Series B Financing to Advance Gene Coding™ – A New Category of Genetic Medicine

  • January 4, 2022

Buyout News WindRose Health Investors Invests in Terrapin Pharmacy

WindRose Health Investors Invests in Terrapin Pharmacy

  • January 4, 2022

Angel / Venture Waymark closes $45M Series A to improve healthcare access and outcomes among Medicaid beneficiaries

Waymark closes $45M Series A to improve healthcare access and outcomes among Medicaid beneficiaries

  • January 3, 2022

Angel / Venture DNA Script Closes $200 Million Series C Financing with Completion of Second Tranche

DNA Script Closes $200 Million Series C Financing with Completion of Second Tranche

  • January 3, 2022

Angel / Venture Rapidly Emerging Digital Health Company DiRx Raises $10 Million in Series A Funding

Rapidly Emerging Digital Health Company DiRx Raises $10 Million in Series A Funding

  • December 27, 2021

Pharma and Healthcare Gyrus Capital's Essential Pharma refinances, inks two deals

Gyrus Capital's Essential Pharma refinances, inks two deals

Essential Pharma, a UK pharmaceutical company backed by Gyrus Capital, has completed a refinancing providing capital to continue its organic and inorganic growth strategy.

We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.
I Accept Cookies
We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.
I Accept Cookies